Subsequent exon sequencing data indicated that the MMR tumor group had high TMB, which may translate to more tumor neoantigens and induce more T cells to attack tumor cells, which is conducive to the success of PD-1 immune drugs. The gene discussed is PDCD1; the disease is neoplasm.